Company Profile
Prokarium Limited
06300883•Private Limited With Share Capital
Get Full Access
03/07/2007
18 years
3
12
72190
high risk
Company Overview
Registration, classification & business activity
Prokarium Limited (06300883) is a private limited with share capital incorporated on 03/07/2007 (18 years old) and registered in london, NW10NH. The company operates under SIC code 72190 - other research and experimental development on natural sciences and engineering.
Prokarium is pioneering the field of microbial immunotherapy. our pipeline is designed to unlock the next level of immuno-oncology by building on the most recent advances in cancer immunology. prokarium’s lead program is focused on transforming the treatment paradigm in bladder cancer by orchestrati...
Financial Overview
£1.55M
£52.79M
£-51.24M
£270.2K
£98.0K
Key Metrics
12
Employees
3
Directors
1
Shareholders
23
Patents
Board of Directors
Charges
2
Registered
0
Outstanding
0
Part Satisfied
2
Satisfied
Innovate Grants
This company received a grant of £33982.0 for A Novel Prophylactic Vaccine And Delivery Platform To Prevent Clostridium Difficile Infections. The project started on 01/05/2016 and ended on 31/10/2017.
This company received a grant of £374331.0 for Newton Fund - Development Of An Oral, Thermostable Enteric Fever Vaccine: Saving Lives And Supporting Tourism In Mexico. The project started on 01/11/2016 and ended on 31/03/2019.
+5 more grants available
Import / Export
Risk Assessment
high risk
International Score
Future Factor
emerging
Performance Rating